JP5219038B2 - Skin keratinization promoter - Google Patents
Skin keratinization promoter Download PDFInfo
- Publication number
- JP5219038B2 JP5219038B2 JP2008276989A JP2008276989A JP5219038B2 JP 5219038 B2 JP5219038 B2 JP 5219038B2 JP 2008276989 A JP2008276989 A JP 2008276989A JP 2008276989 A JP2008276989 A JP 2008276989A JP 5219038 B2 JP5219038 B2 JP 5219038B2
- Authority
- JP
- Japan
- Prior art keywords
- oil
- skin
- keratinization
- acid
- mineral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000003780 keratinization Effects 0.000 title description 27
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 22
- 239000011707 mineral Substances 0.000 claims description 22
- 230000014509 gene expression Effects 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010304 firing Methods 0.000 claims description 2
- 239000008213 purified water Substances 0.000 claims description 2
- 238000006386 neutralization reaction Methods 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 34
- 235000010755 mineral Nutrition 0.000 description 21
- 239000011049 pearl Substances 0.000 description 19
- -1 glycerin fatty acid ester Chemical class 0.000 description 14
- 239000003921 oil Substances 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 102100031784 Loricrin Human genes 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- 108010079309 loricrin Proteins 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000010666 rose oil Substances 0.000 description 3
- 235000019719 rose oil Nutrition 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- 239000005792 Geraniol Substances 0.000 description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- 239000010630 cinnamon oil Substances 0.000 description 2
- 229940043350 citral Drugs 0.000 description 2
- 229930003633 citronellal Natural products 0.000 description 2
- 235000000983 citronellal Nutrition 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 2
- 229940113087 geraniol Drugs 0.000 description 2
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 2
- 229940073665 octyldodecyl myristate Drugs 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 229940056211 paraffin Drugs 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000010675 spruce oil Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 229940012831 stearyl alcohol Drugs 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 101150116870 LORICRIN gene Proteins 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 241000490567 Pinctada Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 241000736892 Thujopsis dolabrata Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000010639 cypress oil Substances 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000004565 granule cell Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
本発明は、皮膚の角化を促進し、皮膚の老化防止、皮膚のトラブル改善に有用な組成物に関する。 The present invention relates to a composition that promotes skin keratinization and is useful for preventing skin aging and improving skin troubles.
皮膚は体の最も外側に存在しており、細菌などの外界からの刺激に対するバリアとしての役割を有している。皮膚においては、表皮細胞が基底細胞から有棘細胞、顆粒細胞、さらには角層細胞へと約4週間かけて変化(角化)し、これらの細胞中で細胞間脂質やNMF(天然保湿因子)、さらにはコーニファイドエンベローブを形成することによってバリア機能を成し遂げている。
しかし、皮膚の老化等によってこの角化の速度は低下することが知られており、角化の速度が低下すると皮膚のくすみや肌荒れなどを引き起こすといわれている。この皮膚の角化を促進する物質としては、タイソウ抽出物やハス胚芽抽出物などの生薬抽出物などが報告されている(特許文献1,2を参照)。
However, it is known that the rate of keratinization decreases due to skin aging, etc., and it is said that when the rate of keratinization decreases, skin dullness and rough skin are caused. As substances that promote the keratinization of the skin, herbal medicine extracts such as peanut extract and lotus germ extract have been reported (see Patent Documents 1 and 2).
しかしながら、これら従来の角化促進成分の作用は十分ではなく、より優れた皮膚角化促進剤の開発が望まれている。
従って、本発明の目的は、皮膚のバリア機能の改善、皮膚の老化防止に有用な皮膚角化促進剤を提供することにある。
However, the action of these conventional keratinization promoting components is not sufficient, and the development of a better skin keratinization promoting agent is desired.
Accordingly, an object of the present invention is to provide a skin keratinization promoter useful for improving the barrier function of skin and preventing skin aging.
そこで本発明者らは、皮膚の角化とともにコーニファイドエンベローブの成分として生成される蛋白質の遺伝子発現量を指標として皮膚角化促進剤を探索してきたところ、真珠層由来のミネラルにロリクリンの遺伝子発現量を増強する作用があり、角化促進剤として有用であることを見出し、本発明を完成した。
すなわち、本発明は真珠層由来のミネラルを含有する皮膚角化促進剤を提供するものである。
Therefore, the present inventors have searched for a skin keratinization promoter using the gene expression level of a protein produced as a component of a cornified envelope together with keratinization of the skin as an index. The present invention was completed by finding that it has an effect of enhancing the amount and is useful as a keratinization promoter.
That is, this invention provides the skin keratinization promoter containing the mineral derived from a pearl layer.
本発明の皮膚角化促進剤は、皮膚の角化とともにコーニファイドエンベローブの成分として生成されるロリクリンの発現を強く促進し、かつ皮膚の角化を促進する。従って、本発明の皮膚角化促進剤を用いれば、皮膚の老化防止、皮膚のトラブル改善効果が得られる。 The skin keratinization promoter of the present invention strongly promotes the expression of loricrin, which is produced as a component of a cornified envelope together with skin keratinization, and promotes skin keratinization. Therefore, if the skin keratinization promoter of the present invention is used, the effects of preventing skin aging and improving skin troubles can be obtained.
本発明に用いられる真珠層由来のミネラル成分は、真珠から脱核した真珠層又は貝殻の真珠層を焼成後、酸又は精製水でミネラルを溶解させ、濾過、中和することにより得ることができる。真珠層由来のミネラルは、カルシウム、ナトリウム、マグネシウム、鉄、亜鉛および微量なミネラルを含有する。乾燥物あたりの主なミネラルの組成比は、カルシウムを50〜99質量%、より好ましくは70〜95質量%含有する。ナトリウムは0〜40質量%、より好ましくは1〜15質量%含有する。マグネシウムは0〜5質量%、より好ましくは0.01〜1質量%含有する。鉄は0〜10質量%、より好ましくは0.5〜5質量%含有する。亜鉛は0〜5質量%、より好ましくは0.01〜1質量%含有する。 The mineral component derived from the pearl layer used in the present invention can be obtained by firing the pearl layer denucleated from the pearl or the pearl layer of the shell, dissolving the mineral with acid or purified water, filtering, and neutralizing. . Minerals derived from the nacre contain calcium, sodium, magnesium, iron, zinc and trace minerals. The composition ratio of the main mineral per dry matter contains 50 to 99 mass%, more preferably 70 to 95 mass% of calcium. Sodium is contained in an amount of 0 to 40% by mass, more preferably 1 to 15% by mass. Magnesium is contained in an amount of 0 to 5% by mass, more preferably 0.01 to 1% by mass. Iron is contained in an amount of 0 to 10% by mass, more preferably 0.5 to 5% by mass. Zinc is contained in an amount of 0 to 5% by mass, more preferably 0.01 to 1% by mass.
後記実施例に示すように、真珠層由来のミネラルを添加すると、皮膚由来細胞はロリクリン遺伝子発現量を増大する。ここでロリクリンは、角質細胞の細胞膜を裏打ちするきわめて強靭で巨大な不溶性構造物である周辺帯の構成成分である。また、真珠層由来のミネラルには、3D皮膚モデルにおける角層形成を促進する作用を有する。従って、真珠層由来のミネラルは皮膚の角化促進剤として有用である。 As shown in Examples described later, when a pearl layer-derived mineral is added, the skin-derived cells increase the loricrin gene expression level. Here, loricrin is a component of the peripheral zone, which is a very strong and huge insoluble structure that lines the cell membrane of keratinocytes. Moreover, the mineral derived from a pearl layer has the effect | action which accelerates | stimulates the stratum corneum formation in a 3D skin model. Therefore, the mineral derived from the nacre is useful as a skin keratinization promoter.
本発明の皮膚角化促進剤は、経口、注射、外用のいずれでも薬効を発現するが、皮膚外用剤として用いるのが好ましい。皮膚外用剤には、皮膚化粧料、外用医薬部外品、医療用皮膚外用剤が含まれる。 The skin keratinization promoter of the present invention exhibits drug efficacy for oral, injection, and external use, but is preferably used as a skin external preparation. Skin external preparations include skin cosmetics, external quasi-drugs, and medical skin external preparations.
また、本発明の皮膚角化促進剤には、上記成分の他に医薬品や化粧品の各種製剤において使用されている界面活性剤、油性成分、保湿剤、高分子化合物、紫外線吸収剤、抗炎症剤、殺菌剤、酸化防止剤、金属イオン封鎖剤、防腐剤、ビタミン類、色素、香料、水等を配合することができる。 In addition, the skin keratinization promoter of the present invention includes surfactants, oily ingredients, moisturizers, polymer compounds, ultraviolet absorbers, anti-inflammatory agents used in various pharmaceutical and cosmetic preparations in addition to the above ingredients. , Fungicides, antioxidants, sequestering agents, preservatives, vitamins, pigments, fragrances, water and the like can be blended.
上記界面活性剤としては、アニオン性、カチオン性、非イオン性、天然、合成のいずれの界面活性剤も使用できるが、皮膚に対する刺激性を考慮すると非イオン性のものを使用することが好ましい。非イオン性界面活性剤としては、例えばグリセリン脂肪酸エステル、プロピレングリコール脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンソルビット脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンポリオキシプロピレングリコール、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリエチレングリコール脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、アルキルグリコシド等が挙げられる。 As the surfactant, any of anionic, cationic, nonionic, natural, and synthetic surfactants can be used, but it is preferable to use a nonionic surfactant in consideration of irritation to the skin. Examples of the nonionic surfactant include glycerin fatty acid ester, propylene glycol fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbite fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene polyoxypropylene glycol. , Polyoxyethylene polyoxypropylene alkyl ether, polyethylene glycol fatty acid ester, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, alkylglycoside and the like.
油性成分としては、油脂類、ロウ類、炭化水素類、高級脂肪酸類、高級アルコール類、エステル類、精油類、シリコーン油類などを挙げることができる。油脂類としては、例えば大豆油、ヌカ油、ホホバ油、アボガド油、アーモンド油、オリーブ油、カカオ油、ゴマ油、パーシック油、ヒマシ油、ヤシ油、ミンク油、牛脂、豚脂等の天然油脂、これらの天然油脂を水素添加して得られる硬化油及びミリスチン酸グリセリド、2−エチルヘキサン酸トリグリセリド等の合成トリグリセリド等が;ロウ類としては、例えばカルナバロウ、鯨ロウ、ミツロウ、ラノリン等が;炭化水素類としては、例えば流動パラフィン、ワセリン、パラフィンマイクロクリスタリンワックス、セレシン、スクワラン、ブリスタン等が;高級脂肪酸類としては、例えばラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、オレイン酸、リノール酸、リノレン酸、ラノリン酸、イソステアリン酸等が;高級アルコール類としては、例えばラウリルアルコール、セチルアルコール、ステアリルアルコール、オレイルアルコール、ラノリンアルコール、コレステロール、2−ヘキシルデカノール等が;エステル類としては、例えばオクタン酸セチル、オクタン酸トリグリセライド、乳酸ミリスチル、乳酸セチル、ミリスチン酸イソプロピル、ミリスチン酸ミリスチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、アジピン酸イソプロピル、ステアリン酸ブチル、オレイン酸デシル、イソステアリン酸コレステロール、POEソルビット脂肪酸エステル等が;精油類としては、例えばハッカ油、ジャスミン油、ショウ脳油、ヒノキ油、トウヒ油、リュウ油、テレピン油、ケイ皮油、ベルガモット油、ミカン油、ショウブ油、パイン油、ラベンダー油、ベイ油、クローブ油、ヒバ油、バラ油、ユーカリ油、レモン油、タイム油、ペパーミント油、ローズ油、セージ油、メントール、シネオール、オイゲノール、シトラール、シトロネラール、ボルネオール、リナロール、ゲラニオール、カンファー、チモール、スピラントール、ピネン、リモネン、テルペン系化合物等が;シリコーン油類としては、例えばジメチルポリシロキサン等が挙げられる。これら上述の油性成分は一種又は二種以上を組み合わせて使用することができる。本発明においては、このうち特にミリスチン酸グリセリド、2−エチルヘキサン酸トリグリセリド、ラノリン、流動パラフィン、ワセリン、パラフィンマイクロクリスタリンワックス、スクワラン、ラウリン酸、ミリスチン酸、パルミチン酸、リノール酸、リノレン酸、イソステアリン酸、セチルアルコール、ステアリルアルコール、オレイルアルコール、コレステロール、オクタン酸セチル、オクタン酸トリグリセライド、ミリスチレン酸イソプロピル、ミリスチン酸オクチルドデシル、イソステアリン酸コレステロール、POEソルビット脂肪酸エステル、ハッカ油、トウヒ油、ケイ皮油、ローズ油、メントール、シネオール、オイゲノール、シトラール、シトロネラール、ゲラニオール、ピネン、リモネン、ジメチルポリシロキサンを使用することが好ましい。 Examples of the oil component include fats and oils, waxes, hydrocarbons, higher fatty acids, higher alcohols, esters, essential oils, silicone oils, and the like. Examples of the fats and oils include soybean oil, nutka oil, jojoba oil, avocado oil, almond oil, olive oil, cacao oil, sesame oil, persic oil, castor oil, coconut oil, mink oil, beef fat, pork fat and the like, and these Hardened oil obtained by hydrogenation of natural fats and oils and synthetic triglycerides such as myristic acid glyceride and 2-ethylhexanoic acid triglyceride; waxes include, for example, carnauba wax, whale wax, beeswax, lanolin and the like; hydrocarbons For example, liquid paraffin, petrolatum, paraffin microcrystalline wax, ceresin, squalane, bristan etc .; higher fatty acids include, for example, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, linoleic acid, Linolenic acid, lanolinic acid, isostearic acid, etc .; Examples of the class alcohols include lauryl alcohol, cetyl alcohol, stearyl alcohol, oleyl alcohol, lanolin alcohol, cholesterol, 2-hexyldecanol, etc .; examples of the esters include cetyl octanoate, triglyceride octanoate, myristyl lactate, cetyl lactate, Examples of essential oils include mint oil, jasmine, isopropyl myristate, myristyl myristate, octyldodecyl myristate, isopropyl palmitate, isopropyl adipate, butyl stearate, decyl oleate, cholesterol isostearate, POE sorbite fatty acid ester, etc. Oil, pepper brain oil, cypress oil, spruce oil, ryu oil, turpentine oil, cinnamon oil, bergamot oil, mandarin oil, ginger oil, pine , Lavender oil, bay oil, clove oil, hiba oil, rose oil, eucalyptus oil, lemon oil, thyme oil, peppermint oil, rose oil, sage oil, menthol, cineole, eugenol, citral, citronellal, borneol, linalool, geraniol, Camphor, thymol, spirantol, pinene, limonene, terpene compounds, etc .; examples of silicone oils include dimethylpolysiloxane. These oily components described above can be used alone or in combination of two or more. In the present invention, among these, myristic acid glyceride, 2-ethylhexanoic acid triglyceride, lanolin, liquid paraffin, petrolatum, paraffin microcrystalline wax, squalane, lauric acid, myristic acid, palmitic acid, linoleic acid, linolenic acid, isostearic acid , Cetyl alcohol, stearyl alcohol, oleyl alcohol, cholesterol, cetyl octanoate, triglyceride octanoate, isopropyl myristate, octyldodecyl myristate, cholesterol isostearate, POE sorbite fatty acid ester, peppermint oil, spruce oil, cinnamon oil, rose Oil, menthol, cineol, eugenol, citral, citronellal, geraniol, pinene, limonene, dimethylpolysiloxane It is preferable to use.
本発明の皮膚角化促進剤には、さらに下記のような成分を配合することができるが、その成分もこれらに限定されるものではない。
(a)色素類;黄色4号、青色1号、黄色202号等の厚生省令に定められたタール色素別表I及びIIの色素、クロロフィル、リボフラビン、クロシン、紅花、アントラキノン等の食品添加物として認められている天然色素等。
(b)ビタミン類;ビタミンA、ビタミンC、ビタミンD、ビタミンE等。
(c)その他;殺菌剤、防腐剤、その他製剤上必要な成分等。
The following components can be further blended in the skin keratinization promoter of the present invention, but the components are not limited thereto.
(A) Dyes: recognized as food additives such as tar dyes I and II dyes, chlorophyll, riboflavin, crocin, safflower, anthraquinone, etc. stipulated in the Ordinance of the Ministry of Health and Welfare such as Yellow No. 4, Blue No. 1, Yellow No. 202, etc. Natural pigments that are used.
(B) Vitamins; vitamin A, vitamin C, vitamin D, vitamin E, etc.
(C) Others: bactericides, preservatives, other ingredients necessary for the preparation, etc.
本発明の皮膚角化促進剤は、前記必須成分に必要に応じて前記任意成分を加え、常法に従って製造することができ、クリーム、乳液、化粧水等の形態とすることができる。 The skin keratinization promoter of the present invention can be produced according to a conventional method by adding the optional components to the essential components as necessary, and can be in the form of cream, milky lotion, lotion or the like.
本発明の皮膚角化促進剤中には、真珠層由来ミネラルを成分1日投与量(乾燥物換算)として1μg〜1g、特に10μg〜100mg配合するのが好ましい。また、本発明の皮膚角化促進剤中に、真珠層由来ミネラルは10μg〜10g/100g、特に40μg〜1g/100g含有するのが好ましい。 In the skin keratinization promoter of the present invention, it is preferable to blend 1 μg to 1 g, particularly 10 μg to 100 mg of the pearl layer-derived mineral as the daily dose of the ingredient (in terms of dry matter). Moreover, it is preferable to contain 10 micrograms-10 g / 100g, especially 40 micrograms-1 g / 100g of pearl layer origin minerals in the skin keratinization promoter of this invention.
次に実施例を挙げて本発明を詳細に説明する。 EXAMPLES Next, an Example is given and this invention is demonstrated in detail.
実施例1
(真珠層由来ミネラルの製造)
アコヤ貝真珠を脱核して、真珠層を取り出す。次に真珠層を破砕して粉末化し、真珠層を焼成する(1050℃、2時間)。水0.85kgに対して、焼成物2gを加え、室温で6時間撹拌する。濾過して不溶分を除去し、濾液に希塩酸を加え中和することにより、アコヤ貝のミネラル溶液を得た。
得られたミネラル溶液には80mg/100mLのカルシウムが含有されており、ミネラルの組成比は、カルシウム:ナトリウム:マグネシウム:鉄:亜鉛=89:8:0.2:3:0.1であった。
Example 1
(Manufacture of pearl layer-derived minerals)
Enucleate Akoyakai pearls and remove the nacreous layer. Next, the pearl layer is crushed and powdered, and the pearl layer is fired (1050 ° C., 2 hours). Add 2 g of the calcined product to 0.85 kg of water and stir at room temperature for 6 hours. The insoluble matter was removed by filtration, and the filtrate was neutralized with dilute hydrochloric acid to obtain a pearl oyster shell mineral solution.
The obtained mineral solution contained 80 mg / 100 mL of calcium, and the mineral composition ratio was calcium: sodium: magnesium: iron: zinc = 89: 8: 0.2: 3: 0.1 .
実施例2
<試験方法>
4系代目の人包皮由来ケラチノサイトを6ウェルのプレート1ウェルあたり2.25×105個播種し、3日間培養(37℃、95%Air、5%CO2)して70〜80%コンフルエントにする。真珠層由来ミネラルを加えて24時間インキュベートし、その後、上清を捨てて、細胞を完全に溶解する。全RNAを抽出し、RNAを逆転写してcDNAを作成し、定量リアルタイムPCRを用いて角化に関連するタンパク質の遺伝子発現量を検出する。
Example 2
<Test method>
4th generation human foreskin-derived keratinocytes are seeded at 2.25 × 10 5 per well of a 6-well plate and cultured for 3 days (37 ° C., 95% Air, 5% CO 2 ) to 70-80% confluence. To do. The nacreous mineral is added and incubated for 24 hours, after which the supernatant is discarded to completely lyse the cells. Total RNA is extracted, RNA is reverse transcribed to produce cDNA, and the gene expression level of protein related to keratinization is detected using quantitative real-time PCR.
<結果>
結果を図1に示す。その結果、真珠ミネラルはロリクリンの遺伝子発現量を増加させることが明らかとなった。
<Result>
The results are shown in FIG. As a result, it was revealed that pearl minerals increased the gene expression level of loricrin.
実施例3
<試験方法>
ケラチノサイトを12ウェルのプレートに播種し、アスコルビン酸を添加した培地で3日間培養(37℃、95%Air、5%CO2)する。真珠層由来ミネラル及び塩化カルシウムを不織布に馴染ませた後、12ウェルの細胞培養表面に乗せて培養する。播種10日後に表皮組織をサンプリングし、固定後パラフィン切片を作成し、HE染色して標本を作製した。
<結果>
結果を図2に示す。その結果、塩化カルシウムを添加したものと比較し、真珠層由来ミネラルを添加した皮膚は、すでに角層下層の形成が始まっていることが確認できた。このことより真珠層由来ミネラルに角化促進効果のあることがわかる。
Example 3
<Test method>
Keratinocytes are seeded in a 12-well plate and cultured for 3 days (37 ° C., 95% Air, 5% CO 2 ) in a medium supplemented with ascorbic acid. The pearl layer-derived mineral and calcium chloride are mixed with the non-woven fabric and then placed on a 12-well cell culture surface and cultured. Ten days after sowing, the epidermis tissue was sampled, and after fixing, a paraffin section was prepared, and stained with HE to prepare a specimen.
<Result>
The results are shown in FIG. As a result, it was confirmed that the formation of the stratum corneum lower layer had already started in the skin to which the pearl layer-derived mineral was added, compared with the case in which calcium chloride was added. This indicates that the pearl layer-derived mineral has a keratinization promoting effect.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008276989A JP5219038B2 (en) | 2008-10-28 | 2008-10-28 | Skin keratinization promoter |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008276989A JP5219038B2 (en) | 2008-10-28 | 2008-10-28 | Skin keratinization promoter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010105924A JP2010105924A (en) | 2010-05-13 |
| JP5219038B2 true JP5219038B2 (en) | 2013-06-26 |
Family
ID=42295741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008276989A Active JP5219038B2 (en) | 2008-10-28 | 2008-10-28 | Skin keratinization promoter |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5219038B2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013023438A (en) * | 2011-07-15 | 2013-02-04 | Mikimoto Pharmaceut Co Ltd | Cornification promoter, filaggrin production promoter, loricrin production promoter, padi-1 production promoter, and histidase production promoter |
| JP6058271B2 (en) * | 2012-02-08 | 2017-01-11 | 御木本製薬株式会社 | Topical skin preparation |
| JP2014024825A (en) * | 2012-07-24 | 2014-02-06 | Mitsuhiro Tomishige | Body-care agent |
| JP6039321B2 (en) * | 2012-09-05 | 2016-12-07 | 御木本製薬株式会社 | Metallothionein production promoter and antioxidant |
| JP2014221748A (en) * | 2013-05-14 | 2014-11-27 | 昭和電工株式会社 | Epidermis-related factor activator |
| KR102142324B1 (en) * | 2014-03-28 | 2020-08-07 | (주)아모레퍼시픽 | Cosmetic compositon comprsing mineral nutrients and quinoa extracts for mosturizing skin |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10167957A (en) * | 1996-12-09 | 1998-06-23 | Kao Corp | Cell adhesion inhibitor |
| JPH10194919A (en) * | 1997-01-16 | 1998-07-28 | Kao Corp | External preparation for skin |
| JP3827259B2 (en) * | 1997-05-16 | 2006-09-27 | 花王株式会社 | Keratinization promoter |
| FR2799125B1 (en) * | 1999-10-05 | 2002-01-18 | Centre Nat Rech Scient | PROCESS FOR THE PREPARATION OF A COMPOSITION BY EXTRACTION OF NACRE, COMPRISING THE COMPLETE COMPONENTS OF THE NACRE, COMPOSITION OBTAINED BY THIS PROCESS AND ITS USE IN PHARMACY AND COSMETICS. |
| JP2004033073A (en) * | 2002-07-02 | 2004-02-05 | Zen Chemicals Co Ltd | Nutritive assistance food containing eel bone marrow oil |
| FR2857588B1 (en) * | 2003-07-17 | 2007-11-30 | Oreal | USE OF BETA-ENDORPHINE, AGENTS EXERCISING BETA-ENDORPHINE-LIKE ACTIVITY IN COSMETICS AND DERMATOLOGY |
| JP2008105947A (en) * | 2005-02-10 | 2008-05-08 | Asada Shokai:Kk | Cream containing burned powder of shell or the like, and method of producing the same |
-
2008
- 2008-10-28 JP JP2008276989A patent/JP5219038B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010105924A (en) | 2010-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5219038B2 (en) | Skin keratinization promoter | |
| WO2006033343A1 (en) | Composition for prevention or alleviation of pigmentation | |
| JP2010105925A (en) | Skin keratinization-promoting agent | |
| JP6356457B2 (en) | Ceramide-containing external preparation composition | |
| JP6362138B2 (en) | Skin external preparation, skin keratinization promoter, tight junction enhancer, skin barrier function enhancer, transglutaminase gene expression promoter, loricrin gene expression promoter, filaggrin gene expression promoter, involucrin gene expression promoter, keratin gene expression promoter Agent, claudin gene expression promoter, occludin gene expression promoter. | |
| JP2001233754A (en) | Emulsion type skin care preparation | |
| JP3249707B2 (en) | Lipolysis accelerator | |
| JP2008019180A (en) | Lipase inhibitor, horney plug formation inhibitor, pore conspicuousness inhibitor and pimple inhibitor | |
| KR101761005B1 (en) | Cosmetic composition containing non-toxic sulfur for sikn moisture, anti-inflammatory and immune enhancement and manufacturing the same | |
| JP2018035145A (en) | Filaggrin production promoter, involucrin production promoter, loricrin production promoter, histidase production promoter, SPRR1B production promoter | |
| JP4704419B2 (en) | Skin keratinization promoter | |
| JP2018002704A (en) | Filaggrin production promoter, involucrin production promoter, loricrin production promoter, and corneo-desmosin production promoter | |
| JP6970952B2 (en) | Kallikrein-related peptidase production promoter, LEKTI production promoter, SLPI production promoter, keratinization normalizer, corneodesmosome degradation normalizer | |
| JP2011195521A (en) | Skin keratinization promoter | |
| JP5408584B2 (en) | Skin immunity enhancer | |
| JP6356944B2 (en) | Claudin production promoter, occludin production promoter, tight junction function enhancer | |
| JP2002068931A (en) | Composition for external use | |
| JP4577596B2 (en) | Hair restorer or hair growth agent and method of use thereof | |
| JP2014040398A (en) | Filaggrin production accelerator, involucrin production accelerator, loricrin production accelerator, corneo-desmosin production accelerator, and others | |
| JP7021762B2 (en) | Kallikrein-related peptidase production promoter, LEKTI production promoter, SLPI production promoter, keratinization normalizer, corneodesmosome degradation normalizer | |
| JP2016135766A (en) | Kallikrein associated peptidase production-promoting agent, lekti production-promoting agent, slpi production-promoting agent, cornification normalizing agent, and corneodesmosome degradation normalizing agent | |
| JP6480133B2 (en) | Claudin production promoter, tight junction function enhancer | |
| JP6039321B2 (en) | Metallothionein production promoter and antioxidant | |
| KR102869149B1 (en) | Composition for skin moisturizing comprising rose flower extract extracted with skin cosmetic solution as a solvent | |
| JP2014101309A (en) | Cystatin a production promoter, skin barrier increasing agent, skin keratinization function increasing agent, and skin roughness preventing agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110603 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20110603 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20121002 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121016 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121116 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121211 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121225 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130220 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130226 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160315 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5219038 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |